GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sinew Pharma Inc (ROCO:6634) » Definitions » Beginning Cash Position

Sinew Pharma (ROCO:6634) Beginning Cash Position : NT$246.68 Mil (As of Jun. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Sinew Pharma Beginning Cash Position?

Sinew Pharma's Beginning Cash Position for the quarter that ended in Jun. 2023 was NT$246.68 Mil.

Sinew Pharma's quarterly Beginning Cash Position declined from Jun. 2022 (NT$551.17 Mil) to Dec. 2022 (NT$338.12 Mil) and declined from Dec. 2022 (NT$338.12 Mil) to Jun. 2023 (NT$246.68 Mil).

Sinew Pharma's annual Beginning Cash Position declined from Dec. 2020 (NT$252.72 Mil) to Dec. 2021 (NT$46.82 Mil) but then increased from Dec. 2021 (NT$46.82 Mil) to Dec. 2022 (NT$551.17 Mil).


Sinew Pharma Beginning Cash Position Historical Data

The historical data trend for Sinew Pharma's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinew Pharma Beginning Cash Position Chart

Sinew Pharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only 24.10 41.79 252.72 46.82 551.17

Sinew Pharma Semi-Annual Data
Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 46.82 1,035.15 551.17 338.12 246.68

Sinew Pharma Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.


Sinew Pharma Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Sinew Pharma's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinew Pharma (ROCO:6634) Business Description

Traded in Other Exchanges
N/A
Address
C516, Building C, Number 99, Lane 130, Section 1, Yuanyuan Road, Nangang District, Taipei, TWN, 11571
Sinew Pharma Inc is a Taiwan based biopharmaceutical company. It focuses on integrated new drug research and development. The company produces liver disease treatment medicines, pain treatment drugs, animal medicines, and other products. Its product portfolio includes SNP-610, SNP-630, SNP-810, SNP-820, SNP-830 and SNP-840.

Sinew Pharma (ROCO:6634) Headlines

No Headlines